CAMKK2 inhibitors (GSK)

N/A

Report date: 2025/01/26 18:52:55
NME

Base Information

Drug NameCAMKK2 inhibitors (GSK)
Drug Alias NameCAMKK2 inhibitors (GlaxoSmithKline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/calmodulin-dependent protein kinase kinase 2 inhibitors
TargetsCalcium/calmodulin-dependent protein kinase kinase 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A